SELLAS Life Sciences Grou... (SLS)
NASDAQ: SLS
· Real-Time Price · USD
1.62
0.07 (4.52%)
At close: Aug 15, 2025, 3:59 PM
1.62
0.19%
After-hours: Aug 15, 2025, 07:58 PM EDT
SELLAS Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.26M | -27.13M | -30.88M | -32.28M | -34.44M | -35.81M | -37.34M | -38.33M | -36.08M | -35.65M | -41.3M | -38.78M | -38.84M | -35.04M | -20.7M | -17.82M | -15.21M | -15.02M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 158K | 245K | 368K | 575K | 499K | 457K | 5.75M | 5.54M | 5.46M | 6.26M | 846K | 846K | 846K |
Stock-Based Compensation | 1.76M | 1.59M | 1.56M | 1.69M | 1.85M | 2.03M | 2.09M | 2.04M | 1.96M | 1.89M | 1.73M | 1.57M | 1.39M | 1.2M | 1.01M | 864K | 735K | 617K |
Other Working Capital | -3.45M | -4.02M | -3.45M | -2.26M | -1.71M | -1.2M | 2.7M | 2.67M | 3.4M | 5.22M | 4.43M | 3.98M | 2.69M | 2.55M | -5.1M | -106K | 631K | -100K |
Other Non-Cash Items | -798K | -489K | -498K | -518K | -533K | 544K | 491K | 319K | 391K | 154K | 10.13M | 5.6M | 5.52M | 4.92M | -4.17M | 255K | 200K | 1.07M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -158K | -245K | -368K | -575K | -499K | -412K | -289.24K | -82.24K | -239 | -815.24K | -838K | -838K | -838K |
Change in Working Capital | -6.06M | -7.69M | -5.59M | -1.96M | 962K | 3.19M | 3.35M | 4.23M | 3.14M | 4.82M | 5.64M | 2.56M | 2.75M | 604K | -7.62M | -931K | -1.11M | -530K |
Operating Cash Flow | -31.36M | -33.71M | -35.4M | -33.07M | -32.16M | -30.04M | -31.41M | -31.74M | -30.59M | -28.79M | -23.81M | -23.63M | -23.77M | -22.9M | -26.02M | -17.62M | -15.37M | -13.86M |
Capital Expenditures | n/a | n/a | n/a | -5.5M | -8.5M | -8.5M | -8.5M | -7.5M | -4.5M | -4.5M | -4.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 5.5M | 5.5M | 3M | 3M | 2M | -2.5M | -4.5M | -4.5M | -9M | -4.5M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | -3M | -5.5M | -5.5M | -10M | -11.5M | -13.5M | -13.5M | -9M | -4.5M | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.37M | 494K | 594K | 640K | 438K | 83K | 36K | -32K | 6K | 6K | n/a | 135K | 99K | 116K | 3.07M | 11.55M | 11.55M | 11.53M |
Financial Cash Flow | 47.51M | 43.69M | 46.76M | 50.14M | 30.5M | 30.06M | 22.32M | 19.86M | 19.91M | 42.94M | 24.08M | 23.2M | 25.34M | 9.12M | 12.07M | 35.7M | 41.95M | 35.14M |
Net Cash Flow | 16.15M | 9.98M | 11.36M | 17.06M | -4.66M | -5.49M | -14.6M | -17.38M | -13.18M | 9.65M | -4.23M | -4.93M | -2.93M | -13.78M | -13.95M | 18.08M | 26.58M | 21.29M |
Free Cash Flow | -31.36M | -33.71M | -35.4M | -38.57M | -40.66M | -38.54M | -39.91M | -39.24M | -35.09M | -33.29M | -28.31M | -23.63M | -23.77M | -22.9M | -26.02M | -17.62M | -15.37M | -13.86M |